Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

about

Multimerin-1 (MMRN1) as Novel Adverse Marker in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group

Item

http://www.wikidata.org/entity/Q35862717

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Multimerin-1 (MMRN1) as Novel ...... the Children's Oncology Group

@ast

Multimerin-1 (MMRN1) as Novel ...... the Children's Oncology Group

@en

type

Item

label

Multimerin-1 (MMRN1) as Novel ...... the Children's Oncology Group

@ast

Multimerin-1 (MMRN1) as Novel ...... the Children's Oncology Group

@en

prefLabel

Multimerin-1 (MMRN1) as Novel ...... the Children's Oncology Group

@ast

Multimerin-1 (MMRN1) as Novel ...... the Children's Oncology Group

@en

P1476

Multimerin-1 (MMRN1) as Novel ...... the Children's Oncology Group

@en

P2093

Alan S Gamis

http://www.w3.org/2001/XMLSchema#string

Betsy A Hirsch

http://www.w3.org/2001/XMLSchema#string

Chelsea J Gudgeon

http://www.w3.org/2001/XMLSchema#string

George S Laszlo

http://www.w3.org/2001/XMLSchema#string

Kimberly H Harrington

http://www.w3.org/2001/XMLSchema#string

Rhonda E Ries

http://www.w3.org/2001/XMLSchema#string

Robert B Gerbing

http://www.w3.org/2001/XMLSchema#string

Soheil Meshinchi

http://www.w3.org/2001/XMLSchema#string

Susana C Raimondi

http://www.w3.org/2001/XMLSchema#string

Todd A Alonzo

http://www.w3.org/2001/XMLSchema#string

P2860

Prevalence and prognostic implications of CEBPA mutations in pediatric acute myeloid leukemia (AML): a report from the Children's Oncology Group

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Analyzing real-time PCR data by the comparative C(T) method

Gene Expression Commons: an open platform for absolute gene expression profiling

Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

Association of a leukemic stem cell gene expression signature with clinical outcomes in acute myeloid leukemia.

High expression of the very late antigen-4 integrin independently predicts reduced risk of relapse and improved outcome in pediatric acute myeloid leukemia: a report from the children's oncology group

Gemtuzumab ozogamicin in children and adolescents with de novo acute myeloid leukemia improves event-free survival by reducing relapse risk: results from the randomized phase III Children’s Oncology Group trial AAML0531.

High expression of suppressor of cytokine signaling-2 predicts poor outcome in pediatric acute myeloid leukemia: a report from the Children's Oncology Group.

Residual disease detected by multidimensional flow cytometry signifies high relapse risk in patients with de novo acute myeloid leukemia: a report from Children's Oncology Group.

P304

3187-3195

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/1078-0432.CCR-14-2684

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Roland B Walter

P577

2015-03-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

25825478

http://www.w3.org/2001/XMLSchema#string

P932

4506237

http://www.w3.org/2001/XMLSchema#string